Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Significant Decline in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) saw a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 31,784 shares, a drop of 61.2% from the June 30th total of 81,924 shares. Based on an average daily trading volume, of 9,525 shares, the days-to-cover ratio is currently 3.3 days.

Relief Therapeutics Stock Up 0.9%

OTCMKTS RLFTF opened at $0.23 on Wednesday. The company has a fifty day moving average of $0.34 and a two-hundred day moving average of $0.71. Relief Therapeutics has a 52 week low of $0.16 and a 52 week high of $4.88.

Relief Therapeutics Company Profile

Relief Therapeutics AG is a clinical?stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF?100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.